Most cited papers from Telesta Therapeutics (Canada)
Telesta Therapeutics (Canada)
What are the most cited papers from Telesta Therapeutics (Canada)?
The most cited paper from Telesta Therapeutics (Canada) is "CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition" (David Gallo et al., 2022), with 245 citations. Next come "The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer" (128) and "Targeting ATR in patients with cancer" (98).
Showing 19 of 19 papers.Every paper is listed.
Most cited papers, sortable by citations and release date
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or
Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation;
retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown.
How the lists are chosen.